Greenwich Lifesciences Inc
NASDAQ:GLSI
Greenwich Lifesciences Inc
NASDAQ:GLSI
Price:
26.74
USD
0.75%
Market Closed
Market Cap:
$370.3m
Balance Sheet
Balance Sheet Decomposition
Greenwich Lifesciences Inc
Greenwich Lifesciences Inc
Balance Sheet Decomposition is not available for
Greenwich Lifesciences Inc
Greenwich Lifesciences Inc
Balance Sheet
Greenwich Lifesciences Inc
Greenwich Lifesciences Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
29
|
27
|
13
|
7
|
4
|
|
| Cash |
0
|
0
|
0
|
29
|
27
|
13
|
7
|
4
|
|
| Total Current Assets |
0
|
0
|
0
|
29
|
27
|
13
|
7
|
4
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+267%
|
0
-73%
|
29
+95 500%
|
27
-5%
|
13
-50%
|
7
-48%
|
4
-41%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
2
|
|
| Long-Term Debt |
8
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
9
N/A
|
10
+20%
|
1
-87%
|
1
-24%
|
0
-63%
|
0
-33%
|
0
+13%
|
2
+430%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
22
|
24
|
27
|
29
|
34
|
41
|
50
|
66
|
|
| Additional Paid In Capital |
14
|
14
|
26
|
57
|
60
|
55
|
57
|
69
|
|
| Total Equity |
9
N/A
|
10
-19%
|
1
+87%
|
28
N/A
|
27
-3%
|
13
-51%
|
7
-49%
|
3
-62%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+267%
|
0
-73%
|
29
+95 500%
|
27
-5%
|
13
-50%
|
7
-48%
|
4
-41%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
12
|
12
|
12
|
13
|
13
|
13
|
13
|
13
|
|
Switch to:
Switch to:
See Also
Discover More
